Enakshi Singh - 28 Dec 2021 Form 4 Insider Report for Zymergen Inc.

Role: Chief Financial Officer
Signature: /s/ Mina Kim, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 28 Dec 2021
Net transactions value: +$85,000
Form type: 4
Filing time: 30 Dec 2021, 15:52:21 UTC
Previous filing: 28 Oct 2021
Next filing: 15 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZY	Common Stock	Options Exercise	$85,000	+50,000	+28%	$1.70	227,000	28 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZY	Stock Options	Options Exercise	$0	-50,000	-100%	$0.000000^*	0	28 Dec 2021	Common Stock	50,000	$1.70	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction by the Reporting Person is an exercise of an in-the-money option for cash consideration and does not involve the sale of any shares.
F2	The shares subject to the Option are fully vested and immediately exercisable.